ReviewCell cycle (Georgetown, Tex.)2010

Racing to block tumorigenesis after pRb loss: an innocuous point mutation wins with synthetic lethality.

Frederick Bauzon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.